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Introduction
As to the metabolic situation at birth on animal species, there 
seem to be two patterns. One is the brains of neurologically precocial 
and mature species, and another is the brains of neurologically non-
precocial and immature species including rat and human. The former can 
have ability of complete oxidation of glucose, which is aerobic glycolysis. 
However, the latter would utilize a mixed metabolism of glucose and 
ketone bodies in order to generate energetic and synthetic activities [1].
Mammals have the ability of converting energy stored in ketone 
bodies (KB) to high energy phosphates. KB can give fuel particularly 
to brain, heart, and skeletal muscle in several conditions, such as 
starvation, adherence to the neonatal period and low carbohydrate 
diets [2]. According to obtained biochemical data and comparison of 
animal species, the fetus in most animals seem to be developed by the 
energy gained from the ketone bodies produced [3]. 
There are 3 kinds of ketone bodies chemically and/or medically, 
including acetoacetic acid (AcAc), beta-hydroxybutyrate (β-HB) and 
acetone [4]. The former two has activity as ketone bodies, and the latter 
has no activity. Among them, β-HB is thought to be the basic engine 
fuel that produces necessary energy on land-living animals. β-HB has 
been known so far as an energy carrier from liver to peripheral tissues. 
Furthermore, it also plays a role of signal via extracellular receptors 
and acts as an endogenous inhibitor of histone deacetylases (HDACs) 
[5]. KB has been estimated to show beneficial efficacy for the nervous 
function and for neurological diseases. According to the study of 
acetoacetyl-CoA synthetase (AACS), KB seemed to be utilized for 
synthesis pathway of lipid substance, and to influence metabolic 
disorder in the nervous system [6]. 
Firstly, a ketogenic diet which contains high ratio of fat has been 
applicable to children with epilepsy. This treatment has been effective 
for long years, and continued at more than 250 medical centers in 
the world [7]. Thus, the potential benefits of ketogenic diet have been 
quite acknowledged. As one of the pediatric problem, there are many 
children with epilepsy who are resistant to standard anti-epileptic 
medicine. In such cases, ketogenic diet would be recommended as an 
alternative treatment. It is effective either high-fat low carbohydrate 
ketogenic diet or meal with high ketone bodies including AcAc, β-HB 
and acetone. The detail mechanism of these meals is not known yet, 
however, in fact KB has anticonvulsant antiepileptic effects [8]. 
However, the influence of carbohydrate depleted meal on the 
metabolic parameters of children has not been adequately evaluated 
yet [9]. Based on the accumulation of cases, the development of 
clinical research on epilepsy would be desired in the future.
Secondly, KB would be beneficial in patients with Alzheimer’s 
disease (AD). In patients with AD, it has been observed that glucose 
metabolism in the brain is specifically reduced [10]. The β-amyloid 
peptide Aβ interferes with their cholinergic innervation [11]. 
Ketone bodies are similarly used against epilepsy at rather high KB 
concentration, in which KB would interfere with glucose and de novo 
synthesis of neurotransmitter glutamate. On contrast, KB can be used 
for AD at lower concentration. The mechanism may be from the effect 
to support of energy metabolism, with possible inhibiting release 
of gliotransmitter glutamate [11]. Pre-symptomatic brain glucose 
hypo-metabolism would be contributing to the onset of AD. As the 
principal KB, β-HB and ACAC are the brain’s main physiological 
alternative fuel to glucose [12].
According to some clinical trials, increasing ketone availability to 
the brain with moderate nutritional ketosis showed a beneficial effect 
on cognitive outcomes in the cases of mild-to-moderate AD [12]. As a 
treatment, mild to moderate ketosis can be safely obtained by a high-
fat ketogenic diet and/or by supplements providing 20-70 g/day of 
medium-chain triglycerides. They may include the 8- and 10-carbon 
fatty acids octanoate and decanoate, or ketone esters. Recently 
developed medicine is Caprylic acid triglyceride, that is registered in 
the United States as a therapeutic food supplement effective for the 
treatment of AD [13].
Consequently, beneficial function of KB would be attributed to 
their ability to increase and improve mitochondrial efficiency and 
restore the supplement of normal reliance on glucose in the brain. 
Successive research concerning the therapeutic potential of KB and 
ketogenic diet would be expected from now, leading to the promising 
new area of research for Alzheimer’s disease [14]. 
There have been various discussions about the efficacy concerning 
CR and LCD. In this regard, studies for animal research have 
been found. There are studies that insects and mice are put in an 
unconstrained environment associated with eating compensation 
freely [15]. As a result, the longest-lived result was obtained in the 
group of diets containing less protein and high carbohydrates [15]. 
It was revealed that the low total energy intake has minimal effect. 
These conclusions will be helpful for intervention studies of humans, 
insects, rodents and others.
On the other hand, many researches have revealed that nutritional 
intervention delays aging and age-related diseases [16]. Among them, 
the most widely performed intervention was calorie restriction, 
and restriction of protein and various amino acids (methionine, 
tryptophan) also showed the retardation of aging process. However, 
it is not yet clarified whether most influential factor may be caloric 
intake, protein intake, or specific amino acid [16]. For nutritional 
therapy, significant amount of controversy was found related to 
the optimal amount of dietary carbohydrate. LCD was initiated by 
Atkins [17]. After that, there have been lots of controversies and 
discussion [18,19]. At present, common understanding for LCD 
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would be that low-carbohydrate, high-protein diets can effectively 
promote weight loss associated with substantive evidence, for many 
ordinary individuals [20]. Standard conception and management for 
LCD was summarized by Feinman et al. [21]. Authors and colleagues 
have continued clinical research about KB and LCD for years. We 
investigated the elevated KB value and M value during the treatment 
for LCD [22]. Moreover, we also clarified the significance of KB in 
the axis of fetus-placenta-newborn-mother [23]. Thus, research on 
ketone bodies and CR/LCD would be expected to develop in future 
study. 
Conclusion
In summary, KB has an important role for human’s life. It can 
generate energy during fetus and newborn and necessary occasion 
without glucose depletion. In middle age, KB would be useful for 
nutritional therapy for metabolic syndrome, and for anti-aging 
medicine. For aged people, KB may contribute the prevention and 
treatment of Alzheimer dementia and other diseases. We expect KB 
research development for health and happiness of everyone.
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